• SENSEX 80,358.58
    70.20 (+0.09%)
  • BANKNIFTY 55,391.25
    -41.55 (--0.07%)
  • Mazagon Dock
    3,149.70 3,047.00(%)
  • Reliance Industr
    1,411.85 1,608.95(%)
  • Garden Reach Sh.
    1,855.00 890.05(%)
  • Bajaj Finance
    8,560.00 6,376.55(%)
  • Cochin Shipyard
    1,600.40 1,169.00(%)
  • Torrent Pharma.
    3,360.00 3,589.95(%)
  • Hind.Aeronautics
    4,466.00 3,045.95(%)
  • Tata Motors
    641.15 542.55(%)
  • Paras Defence
    1,469.00 1,592.75(%)
  • Samvardh. Mothe.
    132.00 107.30(%)
  • Data Pattern
    2,459.05 1,350.50(%)
  • Varun Beverages
    507.45 419.40(%)
  • IndusInd Bank
    810.40 605.40(%)
  • Trent
    5,134.00 4,058.45(%)
  • Bharat Electron
    312.50 221.00(%)
  • Hitachi Energy
    14,879.00 16,534.50(%)
  • ICICI Bank
    1,424.00 1,051.50(%)
  • Sonata Software
    415.25 762.00(%)
  • Tech Mahindra
    1,510.60 1,807.40(%)
  • HDFC Bank
    1,936.40 1,977.95(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Tyche Industries Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 21199.0
  • ISIN : INE443B01012
147.80 0 (0.20%)
  • As on 30 Apr 2025 (EOD)

  • Today’s Low

    146.05

  • Today’s High

    150.10

  • Open

    149.00

  • Perv Close

    147.50

  • 52W Low

    129.10

  • 52W High

    224.50

Key Indicators

  • P/E(TTM)

    11.17

  • Mar.Cap (₹Cr.)

    151.50

  • Div & Yield %

    1.69

  • Book Value(₹)

    130.20

  • Debt-Equity Ratio

    0.20

  • AGM Date

    29-Apr-2025

  • EPS

    13.23

  • P/E Ratio

    11.17

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    151.50

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    10.25

  • BV (₹)

    130.20

  • Sales( ₹ in Cr.)

    69.51

  • NP (in Cr.)

    12.24

  • NP Var(%)

    -14.0

  • Div%

    25.0

  • CPS (₹)

    13.80

  • EPS (₹)

    11.90

  • Traded Value (₹ in Lakhs)

    151.50

  • 52 Week High

    224.50

  • 52 Week Low

    129.10

  • Price BSE

    148.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    151.50

  • P/C Ratio

    10.70

  • P/E Ratio

    12.40

  • Price Vs.BV

    11.90

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 69.51 75.39 62.27 78.24 73.70 53.95
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 69.51 75.39 62.27 78.24 73.70 53.95
Other Income 5.92 4.83 5.11 4.74 3.68 2.52
Stock Adjustments -1.21 2.14 2.57 -0.91 1.18 0.36
Total Income 74.22 82.36 69.95 82.07 78.56 56.83
EXPENDITURE :            
Raw Materials 27.97 35.74 30.23 26.08 29.85 24.10
Power and Fuel Cost 4.13 3.92 2.86 3.83 3.73 2.96
Employee Cost 7.81 6.96 6.68 6.55 7.20 6.99
Other Manufacturing Expenses 7.81 5.87 6.22 8.71 6.48 6.00
Selling and Administration Expenses 7.05 8.01 6.98 6.92 5.52 4.54
Miscellaneous Expenses 0.88 1.00 2.57 1.51 0.72 0.55
Employee Benefit Expenses 7.81 6.96 6.68 6.55 7.20 6.99
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 55.65 61.49 55.53 53.61 53.49 45.13
Operating Profit 18.57 20.86 14.43 28.47 25.07 11.69
Interest 0.00 0.00 0.00 0.01 0.00 0.00
Gross Profit 18.57 20.86 14.43 28.46 25.07 11.69
Depreciation 1.94 1.77 1.79 1.72 1.74 1.84
Profit Before Tax 16.63 19.09 12.64 26.74 23.33 9.85
Current Tax 4.46 5.03 3.39 6.73 6.03 2.98
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.07 -0.12 -0.09 0.02 -0.26 -0.28
Reported Net Profit 12.24 14.17 9.33 19.98 17.56 7.15
Extraordinary Items 0.00 -0.09 -0.51 -0.74 0.01 0.00
Adjusted Net Profit 12.24 14.26 9.84 20.72 17.55 7.15
Adjustment below Net Profit -0.40 -0.19 -0.21 -0.17 -0.14 -0.01
P & L Balance brought forward 99.42 87.08 79.19 60.55 43.94 37.10
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 2.35 1.84 1.32 1.32 0.81 0.30
P & L Balance carried down 108.91 99.23 87.00 79.04 60.55 43.94
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 25.00 0.00 15.00 10.00 0.00 5.00
Dividend Per Share(Rs) 2.50 0.00 1.50 1.00 0.00 0.50
Earnings Per Share-Unit Curr 11.95 13.83 9.11 19.51 17.14 6.97
Earnings Per Share(Adj)-Unit Curr 11.95 13.83 9.11 19.51 17.14 6.97
Book Value 123.70 113.96 101.72 93.66 75.32 58.82
Book Value(Adj)-Unit Curr 123.70 113.96 101.72 93.66 75.32 58.82

Shareholding Pattern

  • Promoter Group

    61.97%

  • Public Share Holding

    38.03%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 4,085,641 39.86 4,085,641 4
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 2,265,855 22.11 2,265,855 6
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 6,351,496 61.97 6,351,496 10
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 747,850 7.30 747,850 44
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 114,365 1.12 114,365 124
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 123,937 1.21 123,937 145
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 465,960 4.55 465,960 11
Individuals holding nominal share capital up to Rs. 1 lakh 2,292,121 22.36 2,164,908 7,088
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 154,271 1.51 154,271 3
Sub Total 3,898,504 38.03 3,771,291 7,415
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 10,250,000 100.00 10,122,787 7,425

Company Background

Tyche Industries LtdPharmaceuticals - Indian - Bulk Drugs

  • Tyche Industries Ltd
  • BSE Code : 21199.0
  • ISIN : INE443B01012

  • Incorporation Year

    1998

  • Registered Office

    H No C-21/A Road No 9
    Film Nagar Jubilee Hills, Hyderabad,
    Telangana-500096

  • Telephone

    91-40-23541688/23540933

  • FAX

    91-40-23540933

  • Chairman

    G Ganesh Kumar

  • Managing Director

    G Ganesh Kumar

  • Company Secretary

    Pradosh Ranjan Jena.

  • Auditor

    P S N Ravishanker & Associates

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    CIL Securities Limited
    214 RaghavaRatna Tow,
    Chiragali Lane,Abids
    Mumbai - Hyderabad 500001

Tyche Industries Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Tyche Industries 147.80 75.43 69.51 11.17 13.41
Abbott India 30,094.35 6,097.18 5,848.91 47.92 44.71
Astrazeneca Phar 8,795.90 1,330.33 1,295.53 226.76 33.26
P & G Health Ltd 5,121.00 1,166.89 1,151.26 35.93 39.76
Glaxosmi. Pharma 2,904.45 3,530.73 3,407.25 57.75 44.44
Cipla 1,541.00 17,645.00 16,574.34 26.42 20.10
Amrutanjan Healt 679.10 437.58 421.23 39.81 20.84
Guj. Themis Bio. 285.15 174.19 169.82 59.04 44.82
Fermenta Biotec. 272.25 315.24 307.09 25.81 4.10
Bliss GVS Pharma 122.65 638.96 605.46 28.07 11.19
Ambalal Sarabhai 37.10 11.70 3.81 15.85 1.92